Biography

Jeff Luber is the CEO of binx health, a clinical diagnostics company that developed the first FDA-cleared, CLIA-waived rapid point-of-care molecular system for sexually transmitted infection testing in the U.S. for both men and women.

A seasoned leader with a focus on the practical application of scientific innovation, Jeff has served as CEO at several healthcare and life science companies, including Good Start Genetics, which was acquired by Invitae Corp., and Exact Sciences Corp., where he played a key role in gaining endorsement from the American Cancer Society for the use of DNA markers in non-invasive colorectal cancer detection.